Engineering of the LAMP-CRISPR/Cas12b platform for Chlamydia psittaci detection

J Med Microbiol. 2023 Dec;72(12). doi: 10.1099/jmm.0.001781.

Abstract

Introduction. Chlamydia psittaci (C. psittaci) is a zoonotic infection, that causes psittacosis (parrot fever) in humans, leading to severe clinical manifestations, including severe pneumonia, adult respiratory distress syndrome, and, in rare cases, death.Gap Statement. Rapid, sensitive and specific detection of C. psittaci facilitates timely diagnosis and treatment of patients.Aim. This study aimed to engineer the LAMP-CRISPR/Cas12b platform for C. psittaci detection.Methodology. The loop-mediated isothermal amplification (LAMP) technique and clustered regularly interspaced short palindromic repeats-CRISPR associated protein 12b (CRISPR-Cas12b) assay were combined to establish two-step and one-tube LAMP-CRISPR/Cas12b reaction systems, respectively, for rapidly detecting C. psittaci.Results. The two-step and one-tube LAMP-CRISPR/Cas12b assay could complete detection within 1 h. No cross-reactivity was observed from non-C. psittaci templates with specific LAMP amplification primers and single-guide RNA (sgRNA) targeting the highly conserved short fragment CPSIT_0429 gene of C. psittaci. The detection limits of the two-step and one-tube LAMP-CRISPR/Cas12b reaction were 102 aM and 103 aM, respectively. The results were consistent with qPCR for nucleic acid detection in 160 clinical samples, including 80 suspected C. psittaci samples, kept in the laboratory.Conclusions. The LAMP-CRISPR/Cas12b assay developed in this study provides a sensitive and specific method for rapidly detecting C. psittaci and offers technical support for its rapid diagnosis.

Keywords: CRISPR-Cas12b; Chlamydia psittaci; LAMP; detection.

MeSH terms

  • Adult
  • Animals
  • CRISPR-Cas Systems
  • Chlamydophila psittaci* / genetics
  • Humans
  • Nucleic Acid Amplification Techniques / methods
  • Psittacosis* / diagnosis
  • RNA, Guide, CRISPR-Cas Systems
  • Zoonoses

Substances

  • RNA, Guide, CRISPR-Cas Systems